The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells

FEBS Letters

Volumn 403, Issue 1, 1997, Pages 26-30

  Léon, Catherine ^a   Hechler, Béatrice ^a   Vial, Catherine ^a   Leray, Claude ^a   Cazenave, Jean Pierre ^a   Gachet, Christian ^a  

^a INSERM   (France)

Author keywords

ADP receptor; Heterologous expression; Human platelet; Megakaryoblastic cell; P2Y1 purinoceptor

Indexed keywords

2 METHYLTHIOADENOSINE 5' DIPHOSPHATE; ADENOSINE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; NUCLEOTIDE; PURINE P2 RECEPTOR; PURINE P2Y RECEPTOR; PYRIDOXAL 5 PHOSPHATE; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG; 5' ADENYLYL (BETA,GAMMA METHYLENE)DIPHOSPHONATE; 5'-ADENYLYL (BETA,GAMMA-METHYLENE)DIPHOSPHONATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; CALCIUM; DRUG DERIVATIVE; MEMBRANE PROTEIN; P2RY12 PROTEIN, HUMAN; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOCHEMISTRY; DNA LIBRARY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; MEGAKARYOBLAST; MEMBRANE TRANSPORT; MOLECULAR CLONING; NONHUMAN; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE; BINDING COMPETITION; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MEGAKARYOCYTE; METABOLISM;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BINDING, COMPETITIVE; BLOOD PLATELETS; CALCIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; JURKAT CELLS; MEGAKARYOCYTES; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; SURAMIN;

EID: 0030614527     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00022-7     Document Type: Article

References (31)

1. Weissman, G.A., Turner, J.T. and Fedan, J.S. (1996) J. Pharmacol. Exp. Ther. 277, 1-9.
2. Burnstock, G. (1978) in: Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (Bolis, L. and Straub, R.N., Eds.), p. 107, Raven Press, New York.
3. Burnstock, G. and Kennedy, C. (1985) Circ. Res. 58, 319-330.
4. Webb, T.E., Simon, J., Krishek, B.J., Bateson, A.N., Smart, T.G., King, B.F., Burnstock, G. and Barnard, E.A. (1993) FEBS Lett. 324, 219-225.
5. Burnstock, G. and King, B.F. (1996) Drug Dev. Res. 38, 67-71.
6. Murgo, A.J. and Sistare, F.D. (1992) J. Pharmacol. Exp. Ther. 261, 580-585.
7. Murgo, A.J., Contrera, J.G. and Sistare, F.D. (1994) Blood 83, 1258-1267.
8. Shi, X.P., Yin, K.C. and Gardell, S.J. (1995) Thromb. Res. 77, 235-247.
9. Hechler, B., Cazenave, J.-P., Hanau, D. and Gachet, C. (1995) Nouv. Rev. Fr. Hematol. 37, 231-240.
10. Hourani, S.M.O. and Hall, D.A. (1996) in: P2 Purinoceptors: Localization, Function and Transduction Mechanisms, pp. 53-70, Wiley, Chichester.
11. Gachet, C., Hechler, B., Léon, C., Vial, C., Ohlmann, P. and Cazenave, J.-P. (1996) Platelets (in press).
12. Sage, S.O., Reast, R. and Rink, T.J. (1990) Biochem. J. 265, 675-680.
13. MacKenzie, A.B., Mahaut-Smith, M.P. and Sage, S.O. (1996) J Biol. Chem. 271, 2879-2881.
14. MacFarlane D.E. (1987) In: Platelet Responses and Metabolism (Holmsen, H. Ed.), pp. 19-36, CRC Press, Boca Raton, FL.
15. Ohlmann, P., Laugwitz, K., Nürnberg, B., Spicher, K., Schultz, G., Cazenave, J.-P. and Gachet, C. (1995) Biochem. J. 312, 775-779.
16. Filtz, T.M., Li, Q., Boyer, J., Nicholas, R.A. and Harden, T.K. (1994) Mol. Pharmacol. 46, 8-14.
17. Tokuyama, Y., Hara, M., Jones, E.M.C., Fan, Z. and Bell, G.I. (1995) Biochem. Biophys. Res. Commun. 211, 211-218.
18. Henderson, D.J., Elliot, D.G., Smith, G.M., Webb, T.E. and Dainty, I.A. (1995) Biochem. Biophys. Res. Commun. 212, 648-656.
19. Léon, C., Vial, C., Cazenave, J.P. and Gachet, C. (1996) Gene 171, 295-297.
20. Schachter, J.B., Li, Q., Boyer, J.L., Nicholas, R.A. and Harden, T.K. (1996) Br. J. Pharmacol. 118, 167-173.
21. Jannsens, R., Communi, D., Pirotton, S., Samson, M., Parmentier, M. and Boeynaems, J.M. (1996) Biochem. Biophys. Res. Commun. 221, 588-593.
22. Hoffman, R. (1989) Blood 74, 1196-1212.
23. Hall, D.A. and Hourani, S.M.O. (1993) Br. J. Pharmacol. 108, 728-733.
24. Simon, J., Webb, T.E., King, B.F., Burnstock, G. and Barnard, E.A. (1995) Eur. J. Pharmacol. 291, 281-289.
25. Barnard, E.A., Webb, T.E., Simon, J. and Kunapuli, S.P. (1996) in: P2 Purinoceptors: Localization, Function and Transduction Mechanisms, pp. 166-188. Wiley, Chichester.
26. Kennedy, C. and Leff, P. (1995) Trends Pharmacol. Sci. 16, 168-174.
27. Nicholas, R.A., Watt, W.C., Lazarowski, E.R., Li, Q. and Harden, T.K. (1996) Mol. Pharmacol. 50, 224-229.
28. Ayyanathan, K., Webb, T.E., Sandhu, A.K., Athwal, R.S., Barnard, E.A. and Kunapuli, S.P. (1996) Biochem. Biophys. Res. Commun. 218, 783-788.
29. Feolde, E., Vigne, P., Breittmayer, J.-P., Frelin, C. (1995) Br. J. Pharmacol. 115, 1199-1203.
30. Humphries, R.G., Tomlinson, W., Clegg, J.A., Ingall, A.H., Kindon, N.D. and Leff, P. (1995) Br. J. Pharmacol. 115, 1110-1116.
31. Humphries, R.G., Tomlinson, W., Ingall, A.H., Cage, P.A. and Leff, P. (1994) Br. J. Pharmacol. 113, 1057-1063.